Cardiovascular imaging artificial intelligence (AI) company Bay Labs announced its EchoMD AutoEF software received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the fully automated clip selection and calculation of left ventricular ejection fraction (EF). EF is the single most widely used metric of cardiac function and used as the basis for many clinical decisions. The EchoMD AutoEF algorithms eliminate the need to manually select views, choose the best clips and manipulate them for quantification, an often time-consuming and highly variable process.
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles and arteries involved in sexual function to preserve potency in patients getting radiation therapy for prostate cancer.
New findings in the current issue of The American Journal of Managed Care suggest that getting the right patients to participate in low-dose computed tomography (LDCT) lung cancer screening is more difficult than expected under the Affordable Care Act.
Fujifilm’s APERTO Lucent is a 0.4T mid-field, open MRI system addressing today’s capability and image quality needs ...
3D Systems announced availability of its new On Demand Anatomical Modeling Service. This new service provides a wide range of medical professionals with access to anatomical models 3-D-printed from their 3-D digital files, enabling enhanced three-dimensional visualization for surgical planning as well as patient education.
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark, clearing the technology for commercial sales and clinical use in Europe.
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
June 15, 2018 —The Weight-Bearing CT International Study Group will host a scientific session on the benefits of weight ...
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
The Office of the U.S. Trade Representative (USTR) released the much-anticipated list of Chinese-manufactured goods that will be subjected to 25 percent tariffs, and medical imaging equipment systems and parts feature prominently on the list.
Agfa announced that it has installed two DX-D 300 digital radiography (DR) solutions at the multi-office Centers for Advanced Orthopaedics, Potomac Valley Orthopaedic Associates Division, in Maryland. The DX-D 300s are replacing a previous, early-generation DR system.
A recent survey of California women found that 95 percent of respondents want the state’s breast density inform law to extend beyond its current Jan. 1, 2019 expiration date. The survey, conducted by global nonprofit breast health organizations Are You Dense Inc. and Are You Dense Advocacy Inc., also found that nearly 75 percent of women know that dense breast tissue makes it more difficult to see cancer on a mammogram, suggesting the 2013 law has been effective in its aim.
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
June 14, 2018 — NeuroLogica, a subsidiary of Samsung Electronics Co. Ltd., announced that Florida Hospital in Orlando ...
International Medical Solutions (IMS) recently announced that the American College of Radiology (ACR) added IMS' Educational Toolkit to the ACR technology portfolio that supports medical imaging education. IMS will provide an option to users of ACR Cortex that includes the ability to perform true DICOM viewing and engage in interactive, web-based assessments. The IMS toolkit will be utilized for projects that include resident training, CME, and other ACR educational programs throughout North America that involve a dynamic educational and assessment experience.
Hitachi Medical Systems Europe has been awarded the contract to supply six ultrasound systems as part of the RAPID program to improve prostate cancer diagnosis across South West London. In addition to the six high-resolution Arietta ultrasound systems, the contract also includes six BiopSee image-guided fusion biopsy systems from MedCom (for which Hitachi is a European distributor) to be installed at three major hospitals. Using the two systems together will allow providers to combine multiparametric magnetic resonance imaging (mp-MRI) data with real-time ultrasound, reducing unnecessary biopsies and providing accurate targeting while reducing the number of samples needed.
Did you know that approximately one-third of all the data in world is created by the healthcare industry and that ...
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St ...
Riverain Technologies announced that the United States Patent and Trademark Office (USPTO) has awarded the company a broad patent for its artificial intelligence (AI) computed tomography (CT) technology. The technology in question forms a vessel suppressed, chest CT series using deep learning and synthetic data modeling. The company said the patent holds promise for improving the detection and diagnosis of lung cancer at an earlier stage while making clinicians more efficient, a first for computer-aided detection (CAD).
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
This is a 360 degree image from the Canon Aquilion 64-slice computed tomography (CT) system installed at Northwestern ...
EOS imaging announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its hipEOS 3.0 surgical planning software.
Artificial intelligence (AI) platform provider EnvoyAI recently completed their first successful customer installation at Wake Radiology in Raleigh, N.C. Wake Radiology is using the platform to provide physicians access to EnvoyAI’s growing marketplace of over 53 AI engines that may be applied to their medical imaging studies. Wake Radiology selected EnvoyAI as the fastest and most comprehensive means to achieving a complete AI strategy for the diverse breadth of clinical services that it provides for patients and referring physicians.
A recently presented investigational clinical trial evaluated the impact of 18F fluciclovine positron emission tomography/computed tomography (PET/CT) imaging on patient management of biochemically recurrent prostate cancer after initial prostate cancer treatment and negative or equivocal findings on standard-of-care imaging. The LOCATE trial is a prospective, multi-center, open-label study (NCT02680041) conducted at 15 sites in the United States. Its primary endpoint measured the percentage of men with suspected biochemical recurrence of prostate cancer following initial prior therapy whose treatment plan was changed following an 18F fluciclovine PET/CT scan.
Peter Chang, M.D., current neuroradiology fellow at UCSF and recently recruited co-director of the UCI Center for Artificial Intelligence in Diagnostic Medicine (CAIDM), is the honorary recipient of the Cornelius G. Dyke Memorial Award. The award was given by the American Society of Neuroradiology (ASNR) for Chang’s work in developing a customized deep learning system with over 97 percent accuracy in near real-time detection of hemorrhage on non-contrast computed tomography (NCCT) exam of the head.
Recently published data from two new studies demonstrate the benefits of Accuray’s TomoTherapy System in the delivery of total body irradiation (TBI). TBI is a procedure commonly used to prepare patients being treated for leukemia and multiple myeloma for a bone marrow transplant. It involves irradiation of the entire body, elevating the need for precision, accuracy and homogeneity in radiation dose delivery. The TomoTherapy platform's architecture enables efficient and effective delivery of radiation over large areas of the patient, making it a valuable part of the bone marrow transplantation conditioning regimen.